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Ayurveda is an experience based knowledge system 
transformed from Guru (Faculty) to Sisya (Scholar). 
Some of the primitive knowledge is in written form as 
available in different Samhita and others were 
clarified by teachers. This knowledge base is in 
scattered form.  Now a day’s Ayurveda is also counted 
under science.  Science has two components, first one 
is  the body  knowledge  and  its  process by which the 
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knowledge is produced and the second component is 
the way of thinking and knowing about the problem. 
The scientific process is the way of building 
knowledge and making prediction about the 
knowledge gap with sufficient justification and in 
testable form. Scientists use their intellect with the 
aid of instruments that extend their sense, reviewing 
various scientific literatures and careful observation of 
his hypothesis leads to the invention of new theories. 
Many times scientists deliberately shared their view 
with other colleagues through publication in peer 
review journals.[1] Ayurveda has its basic frame work 
and its own understanding of patho-physiology 
(Samprapti) of diseases.  
If any new epidemic outbreak or more prevalent 
disease came for treatment, then a basic 
understanding of the symptom of said problem should 
understood in light of Ayurveda.[2] Previously adipose 
tissue was considered as inert tissue in modern 
medicine that stores fat only but now it is an 
endocrine gland as understanding of its role in 
A B S T R A C T  
Meda Dhatu (Adipose tissue) was considered as inert tissue that stores fat only but now it is an 
endocrine gland which controls coagulation, appetite regulation, immunity, glucose and lipid 
metabolism, reproduction, angiogenesis, fibrinolysis, body weight homeostasis and vascular tone 
control. Meda is the fourth Dhatu (stable constituent of body) as per Ayurveda doctrine and resemble 
with the adipose tissue. Meda can create not only Sthyaulya (Obesity) in general but also organ 
specific disorders like - Medaja Granthi , Medaja Masurika, Medaja Galaganda, Medaja Vridhi etc. 
Yakritmeda is found in Sanskrit literature.  But Medaja Yakritdalludara or Yakrit Vikar is not 
enumerated in classical Ayurveda literature. Strong evidences suggested that accumulation of lipids in 
non-adipose tissues can contribute to cellular dysfunction and cell death, a phenomenon that is called 
lipotoxicity. Various components of Meda and its function found in Ayurveda literature are discussed. 
Multiple factors hit hypothesis for Samprapti (pathogenesis) of Medaja Yakrut Vikara (Fatty liver 
disorders) and its progression with preventive and curative strategies are described with scientific 
evidences.    
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controls coagulation, appetite regulation, immunity, 
glucose and lipid metabolism, reproduction, 
angiogenesis, fibrinolysis, body weight homeostasis 
and vascular tone control.[3]  Ayurveda considered 
Meda (adipose tissues) as Dhatu (major functional 
and structural unit).  Now a day’s fatty liver is 
common even among obese children. It also found 
that change in structure and function of adipose 
tissues have significant systemic and hepatic 
consequences.[4]  Previous studies has shown that 
weight loss more than 7% of BMI have better 
outcome in fatty liver which points towards the fact 
that adipose tissue has positive relation in 
predisposing fatty liver.[5] It can also be analysed in 
Ayurveda point of view.  
Ayurveda considered Dosha Dhatu and Mala as basic 
component of body and their balanced and 
imbalanced state of are known as health and disease 
respectively. Vata, Pitta and Kapha are three humors 
(Tridosa) which functional aspect of living things. 
Dhatus  are seven in number which are structural 
entity of body. Malas (Body waste) are waste product 
of Ahara (diet) and Dhatu and their proper excretion 
is very vital for homeostasis.   
Dhatvagni Paka  (component responsible for tissue 
metabolism) is a process in which convert the Dhatu 
to Poshakadhatu (immobile and storage part) and 
Poshya Dhatu (mobile part). This Poshya Dhatu which 
is the  moveable part circulate in its own Srotas  for 
the nutrition of successive Dhatu whereas Poshaka 
part act as storage and in emergence condition can be 
utilized as Poshya Dhatu. Again Bhutagni Paka carried 
out inside the cell for various nutrients utlised for 
cellular function. They maintained homeostasis in the 
principle of Svabhava Satmya (immunity),  Samanya 
and Vishesha (theory of homologous and 
analogous).[6] The Bio energy (Bala) is important 
aspect in Ayurveda for the pathogenesis of any 
diseases. It provides strength to all Dhatu, protect 
them and Kostanga (organ) from Krimi (Infection) and 
Aghata (injury) and provide stability of different 
organ. It works as immune surveillance and maintain 
homeostasis.  Dhatu Paka is a condition of 
suppuration or destruction of Dhatu due to excess 
Agni (heat) or Srotarodha (Block of passage) or Kshaya 
(malnutrition). The cardinal sign of Dhatupaka are 
Nidranasha (sleeplessness), Hrudistambha (heaviness 
/ discomfort of chest), Vistabha (constipation), 
Gaurabha (heaviness of body), Aruchi (Anorexia), 
Arati (Anxiety or dullness) and Balahani (Loss of 
strength/immunity).[7] Dhatu Rupantara (Change of 
architecture of tissues) is a stage where one Dhatu is 
changed to another Dhatu, Upadhatu or  Mala, 
example - Mamsa Dhatu changed to Meda Dhatu or 
Mamsa Dhatu changed to Kandara. 
Meda Dhatu and its components 
Meda is the fourth Dhatu  as per Ayurveda doctrine  
and resemble with the adipose tissue.  If the Meda 
Dhatvagni (Digestive power/ adipokines) deregulated 
than there is a disharmony of distribution of Baddha 
Meda (store in particular site)  and Abaddha Meda 
(circulating fat). This Baddha Meda  can be termed as 
Visceral fat  and Abaddha Meda can be understood as 
circulating lipids. Durmeda is another term found in 
Ayurvedic literature which is nothing but Ama of 
Meda. Durmeda can be understood as free fatty acid. 
Excess  Abadhha Meda / Durmeda are  responsible for 
accumulation in any Dhatu, Srotas, Kostanga, Sira, 
Granthi  etc.  and form Gara Visha (lipotoxicity) and 
disease process initiated. Meda Dhatu is nourished 
from Sneha (fatty food) as per Madhava Nidana.[8]  Its 
distribution in Mamsa Dhatu as Vasa (subcutaneous 
fat) Updhatu and in small bones as Sarakta Meda (red 
bone marrow). The different components of Meda 
and their function are described and found all are 
directly or indirectly responsible for Yakrit Roga (Table 
1). Form this phenomena it can be concluded that 
Meda can create not only as Sthyaulya (Obesity) but 
also organ specific disorders like - Medaja Granthi, 
Medaja Masurika, Medaja Galaganda, Medaja Vridhi 
etc. But Medaja Yakritdalludara  or Yakrit Vikara is 
not enumerated in classical Ayurvedic  literature. 
Strong evidence suggested that accumulation of lipids 
in non-adipose tissues can contribute to cellular 
dysfunction and cell death, a phenomenon that is 
called lipotoxicity.[9]   
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Like that due to hypo function of Jatharagni and 
Medodhatwagni leads to more production of 
Abaddha Meda and Durmeda leading to accumulation 
in all Srotas including  Raktavaha, Mamsavaha and 
Medovaha Srotas.   Sneha Guna in liver will increase 
due to accumulation of Meda as Pitta and Meda have 
Sneha Guna.  Therefore there is deregulation of  Pitta 
production as triggered by Sneha Guna. Another 
events is that more Kleda production is initiated due 
to reduced Ushna and more influx of Rasadhatu.   
Pitta is not excreted out properly due to Srotorodha 
(obstruction of channels).  This primary situation leads 
to accumulation of Durmeda in Yakrit known as 
Medaja Yakrit Dalludara (fatty liver). The further 
development of the disease involves a variety of 
mechanisms, including Sneha Ahara,  hypo function of 
Jatharagni, Dhatvagni, Bhutagni, Durmeda Visha 
(endotoxins and lipotoxicity) ), Sthaulya (obesity) and 
Kapha Prakruiti (genetic predispositions) for Dhatu 
Paka (necrosis of hepatocyte) and Dhatu Rupantara 
(Fibrosis).  
As Yakrit is chief organ of Raktavaha Srotas and intake 
of the Vidahi, Snigdha and Ushna Annapaana along 
with exposure to excessive sunlight and air lead to 
Raktavaha Srotodushti. Again it exposed to various 
threats of Krimi (infection) as it is a Raktakshaya  and 
various nutrients of  Ahara Rasa  as literature 
supports that Ahara Rasa is first received 
by Jyotisthana (Liver) which further nourishes the 
whole body.  
Therefore Bala (Immunity) played a key role in the 
pathogenesis of Yakrit Vikara. The Bala of different 
components of Meda, its Bhautic compositions and its 
strength are stated (Table 2). As Meda and Prakruta 
Kapha are same and similar properties, so they have 
definite role in formation of Bala.[11],[12]  
It is also found that tissue resident macrophages are 
serving as immune sentinels and they interact with 
parenchyma cells to boost immunologic well being.[13]  
Adipokine released from fat cells have a definite role 
on regulatory T cell population, hypertrophy and 
hyperplasia of adipose tissue.[14-16] 
Table 1: Various component of Meda found in 
Ayurveda literature and its function.  









formation of sweat   
Abaddha 
Meda 




Durmeda Free Fatty Acid 
(FFA) 
Ama Visha (lipotoxin) 
Sarakta Meda Myeloid tissue  Asthimpurana and 
formation of Shukra  
Vasa  Subcutaneous 
fat  
Unctuousness  
Yakrimeda  Hepatic TG Store in liver  
Table 2: Major contributors of Bala (Immunity) in 
Yakrit  and its Bhautik composition and level of Bala.  
Component  Bhautik 
composition 
Bala ( Immunity) 
Level  








No Immunity  




Rakta  Prithivi(+), 
Jala(++),Agni(++) 
Immunity(++) 
Ojus  Prithivi(+), 
Jala(++),Agni(++) 
Immunity(++++) 
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Figure 1: Multiple factors hit hypothesis for 
Samprapti (Pathogenesis) of  Medaja Yakrut Roga 
and its progression. 
 
Hypothesis of Medaja Yakrit Sotha and its 
progression 
Yakrit Dalludara is the commonest complication of 
Udara Roga (abdominal diseases) where Yakrit (Liver) 
is clearly palpable due to its increase in size. 
Deposition of Meda / Yakritmeda is said to be one of 
cause of Yakrit Dalludara. Nonalcoholic fatty liver 
disease (NAFLD) encompasses a spectrum of diseases 
that from simple steatosis (pure NAFLD) can progress 
to nonalcoholic steatohepatitis (NASH), cirrhosis and 
hepato-cellular carcinoma. NAFLD progression seems 
to involve the occurrence of "parallel, multiple-hit" 
injuries, such as oxidative stress induced 
mitochondrial dysfunction, endoplasmic reticulum 
stress, endotoxin-induced, TLR4-dependent release of 
inflammatory cytokines, and iron overload, among 
many others. These deleterious factors are 
responsible for the triggering of a number of signaling 
cascades leading to inflammation, cell death, and 
fibrosis, the hallmarks of NASH.[12] Hamza El Hadi et al. 
published a multiple parallel hit hypothesis of NAFLD 
and its progression in figure which is well 
representation of the pathophysiology of modern 
medicine. In the same way the samprapti 
(pathophysiology) hypothesis of Medaja Yakrit Roga 
can be enumerate and explainable.[17-19]  
Generally Kaphaja Prakriti (A type of genetic and 
epigenetic factor) person are more inclined towards 
excess intake of fat diet and progressively developed 
Sthaula (obesity). Sthaula (obesity) together with 
Sneha Ahara (Fatty dietary habit) and less physical 
exercise leads to increase Abadha Meda (blood lipid)  
and vitiate the Kayagni first instant then Medagni 
Vaisyamya (alteration of fat metabolism). Dysfunction 
of Kayagni produce more Durmeda (FFA) and 
decrease the power of Medagni. It affects the 
Dhatwagni and all three Doshas are aggravated and 
get localized in liver. so Yakrit Vikara are Tridosaja. 
There is an increase of Snigdha Guna and decrease of 
Ushna Guna triggered to produce more Kapha inside 
Liver. The deposition of  Kapha and Durmeda leads to 
Yakruit Vridhi in first instance where all symptom of 
Kapha are seen and our Acharya described as Kaphaja 
Udara so called steatosis (pure NAFLD).  Further 
accumulation of Durmeda leads to produce Kleda. 
That Kleda along with  Yakrimeda[20] (hepatic FFA) 
produce Sopha (hepatic inflammation) in Yakrit and 
Dhatu Rupantara (Parenchymal change to hepatic 
stellate cells) takes place after Dhatu Paka. This 
condition is relatable to  NASH (nonalcoholic 
steatohepatitis) (Figure 1). Yakrimeda (Hepatic FFA) 
directly block the Srotas and Srotamula of Yakrit, 
therefore portal hypertension and cholagitis takes 
place. As a result there is a blockage of intra and extra 
hepatic duct leads to accumulation of bile and 
Jaundice.  If more Pitta accumulated then Ushna 
(Heat)  and Drava (Liquid) properties of Pitta triggered 
further for  Dhatu Rupantara (Fibrosis)  then Yakrit 
Kshaya (Cirrhosis) takes place in one way and 
Yakrutdalludara (Hepato cellular carcinoma) in other 
ways or both.   Ayurveda literature says all Udara 
Roga (Hepato biliary disorders) converted to 
Jalaodara.   If all Srotas are involved then various 
complication like - Portal hypertension, Variceal 
bleeding, Hepatic encephalopathy, hepato renal 
syndrome, Ascites etc.  takes place.  
Preventive and Curative Strategies 
Sushruta stated that avoid the etiological factor 
(Nidana Parivarjana) is one of the strategies of  
prevention and cure for all diseases. As Sneha (Fatty 
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diet) responsible for fatty infiltration of liver, 
therefore low fat diet as  recommended by doctor can 
prevent further progress and correction Medaja Yakrit 
Vikara. As Vyayama (Exercise) increase Agni and 
reduce fat, therefore Physical exercise as 
recommended by Ayurveda physician  should practice 
in house.[21],[22]  As Agni is one of the causes for Meda 
deposition. Meda and Kaphahara Dravya is one of the 
treatment strategies for Medaja Yakrit Vikara. 
Srotashodhaka and Pramathi Drava can be employed 
for treatment. So multi modalities treatment as per 
the Samprapti Ghataka (pathogenic factors) can be 
designed. Fourteen herbs and two metal Bhasma are 
screened from various formulations indicated for 
Yakrit Vikara (Table 3). 
Table 3: Various compound used in Medaja Yakrit 
Dalludara.  
SN Name of 
Dravya  
Latin Name  Mode of 
action  
Indication  



























Vrana, Meha  
5. Maricha  Piper nigrum  
Linn.  
Kapha 
Medahara   
Gulma, Udara 
6. Katuki  Picrorhiza 




a, Kusta  




























































Tamra  Tamra 
Bhasma  
Leekhaniya Yakrit , 
Kamala 
DISCUSSION 
Ayurveda considered Meda as Dhatu, its  increase or 
decrease of quantity and quality may create diseases. 
Yakrit Meda[24] word is found in Sanskrit glossary 
which implies fat in liver or fatty liver.  But role of 
Meda in Yakrit Roga is not enumerated in Ayurveda 
classical literatures. As the understanding of 
pathophysiology of fatty liver increased then it was 
thought to create the samprapti of Meda in Yakrit 
Vikara (diseses of liver). The deposition of Kapha and 
Durmeda  leads to Yakruit Vridhi in first instance 
where all symptoms of Kapha are seen. Kapha and 
Meda has similar Bhautic composition and properties. 
Therefore Kaphaja Udara is quite similar with fatty 
liver symptom and many contemporary Ayurveda 
practitioner treating fatty liver (steatosis and NASH) 
as Kaphaja Udara. It is stated that majority of hepatic 
lipids in NAFLD are stored in the form of triglycerides. 
In patients with NAFLD hepatic lipid loading appears 
to be mainly determined by the availability of FFA 
from circulation. Hepatic TG is good fat whereas 
Hepatic FFA is bad fat and there is an alteration of 
lipid metabolism.  Obesity together with dietary 
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habits and environment factor can lead to raised free 
fatty acid (FFA) and cholesterol, developed insulin 
resistance, adipocyte proliferation and worsening 
adipocyte dysfunction and release of pro-
inflammatory adipokines. This is similar to our 
Kayagni and Meda Dhatvagni Vaisamya. Similar 
attempt was made by other scholars also.[23] Ayurveda 
enumerated altered function  of Kayagni produce 
Durmeda where altered activity of gut microbiome 
leads to accumulation of triglyceride and toxic level  
of FFA, free cholesterol and other lipid metabolites 
causes mitrochondrial dysfunction leading oxidative 
stress and activation of the unfolded protein response 
(UPR) leading to hepatic inflammation and 
fibrogenesis which very similar with Dhatu Paka and 
Dhatu Rupantara. The listed medicinal plants have 
Meda & Kaphahara, Deepana, Pachana, Lekhaniya, 
Rakta Shodhaka, Srotoshodhaka and Pramathi 
pharmacological qualities are acting on Medaja Yarit 
Vikara in experimental model and few case and 
clinical studies.[24-27]  
CONCLUSION 
Meda has a key role for the genesis of Yakrit Vikara 
and its progression from Yakrit Meda to 
Yakritdalludara. The medicinal plants having  Meda 
Kaphahara pharmacological qualities will  act on 
Medaja Yarit Vikara. Further clinical study on Meda 
Kaphahara Dravya in Yakrit Vikara is recommended.   
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